Preview Mode Links will not work in preview mode

Aug 28, 2018

The human kinome comprises 518 known protein kinases and more than 20 lipid kinases. Nearly all aspects of control within a cell are modulated by reversible phosphorylation of proteins, mediated by protein kinases.

Abnormal phosphorylation is a cause or effect of many diseases including cancer and inflammatory diseases, hence many pharma and biotech companies continue to undertake research and development in this area believing it to be of clinical importance.

While we can congratulate ourselves on our success in identifying more than 37 kinase inhibitor compounds that have made it to patients and more than 250 drug candidates that are undergoing clinical evaluation, arguably we have only scratched the surface of kinase biology.

Original article by Dr Gary Allenby

If you'd like to view the original article then follow the link below:

https://www.ddw-online.com/drug-discovery/p322102-kinases-application-of-new-assay-technologies-to-shed-light-on-kinase-drug-discovery.html

You can also download the original article pdf here:

https://www.ddw-online.com/media/32/129243/(6)-kinases-old-dogs-and-new-tricks.pdf

To register for our NEW upcoming webinar:

https://www.ddw-online.com/webinars/p322511-multiplexing-specificity-and-species-cross-reactivity-assays-in-biologics-discovery.html

For more information on Drug Discovery World, head to:

https://www.ddw-online.com